| Targeting CD47 as a novel immunotherapy for multiple myeloma J Sun, B Muz, K Alhallak, M Markovic, S Gurley, Z Wang, N Guenthner, ... Cancers 12 (2), 305, 2020 | 67 | 2020 |
| Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma P de la Puente, MJ Luderer, C Federico, A Jin, RC Gilson, C Egbulefu, ... Journal of Controlled Release 270, 158-176, 2018 | 56 | 2018 |
| Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma C Federico, K Alhallak, J Sun, K Duncan, F Azab, GP Sudlow, ... Nature communications 11 (1), 6037, 2020 | 51 | 2020 |
| Localized delivery of cisplatin to cervical cancer improves its therapeutic efficacy and minimizes its side effect profile C Federico, J Sun, B Muz, K Alhallak, PF Cosper, N Muhammad, A Jeske, ... International Journal of Radiation Oncology* Biology* Physics 109 (5), 1483-1494, 2021 | 48 | 2021 |
| Tumor-associated macrophages in multiple myeloma: Advances in biology and therapy J Sun, C Park, N Guenthner, S Gurley, L Zhang, B Lubben, O Adebayo, ... Journal for immunotherapy of cancer 10 (4), 2022 | 46 | 2022 |
| Nanoparticle T-cell engagers as a modular platform for cancer immunotherapy K Alhallak, J Sun, K Wasden, N Guenthner, J O’Neal, B Muz, J King, ... Leukemia 35 (8), 2346-2357, 2021 | 41 | 2021 |
| Single-cell transcriptomic analysis of endometriosis MAS Fonseca, M Haro, KN Wright, X Lin, F Abbasi, J Sun, L Hernandez, ... Nature Genetics 55 (2), 255-267, 2023 | 36 | 2023 |
| Thermal sensitive liposomes improve delivery of boronated agents for boron neutron capture therapy MJ Luderer, B Muz, K Alhallak, J Sun, K Wasden, N Guenthner, ... Pharmaceutical research 36, 1-8, 2019 | 29 | 2019 |
| Cadherin-11, Sparc-related modular calcium binding protein-2, and Pigment epithelium-derived factor are promising non-invasive biomarkers of kidney fibrosis IM Schmidt, MR Colona, BR Kestenbaum, LG Alexopoulos, R Palsson, ... Kidney international 100 (3), 672-683, 2021 | 26 | 2021 |
| CD47-targeting antibodies as a novel therapeutic strategy in hematologic malignancies J Sun, Y Chen, B Lubben, O Adebayo, B Muz, AK Azab Leukemia Research Reports 16, 100268, 2021 | 20 | 2021 |
| BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma E Weisberg, B Chowdhury, C Meng, AE Case, W Ni, S Garg, M Sattler, ... Blood cancer journal 12 (7), 110, 2022 | 14 | 2022 |
| Bispecific T cell engagers for the treatment of multiple myeloma: achievements and challenges K Alhallak, J Sun, A Jeske, C Park, J Yavner, H Bash, B Lubben, ... Cancers 13 (12), 2853, 2021 | 10 | 2021 |
| A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myeloma K Alhallak, A Jeske, P de la Puente, J Sun, M Fiala, F Azab, B Muz, ... Scientific reports 11 (1), 19343, 2021 | 8 | 2021 |
| Nanoparticle T cell engagers for the treatment of acute myeloid leukemia K Alhallak, J Sun, B Muz, A Jeske, J Yavner, H Bash, C Park, B Lubben, ... Oncotarget 12 (19), 1878, 2021 | 8 | 2021 |
| CXCR4-targeted PET imaging using 64Cu-AMD3100 for detection of Waldenström Macroglobulinemia B Muz, N Bandara, C Mpoy, J Sun, K Alhallak, F Azab, BE Rogers, ... Cancer biology & therapy 21 (1), 52-60, 2020 | 8 | 2020 |
| CXCR4-targeted PET imaging using 64Cu-AMD3100 for detection of Waldenström Macroglobulinemia B Muz, N Bandara, C Mpoy, J Sun, K Alhallak, F Azab, BE Rogers, ... Cancer biology & therapy 21 (1), 52-60, 2020 | 8 | 2020 |
| Triptolide reverses apatinib resistance in gastric cancer cell line MKN45 via inhibition of heat shock protein 70 F Teng, ZY Xu, H Lyu, YP Wang, LJ Wang, T Huang, JC Sun, HT Zhu, ... Zhonghua Zhong liu za zhi [Chinese Journal of Oncology] 40 (2), 92-98, 2018 | 8 | 2018 |
| 3D tissue engineered plasma cultures support leukemic proliferation and induces drug resistance K Alhallak, P de la Puente, A Jeske, J Sun, B Muz, MP Rettig, I Sahin, ... Leukemia & Lymphoma 62 (10), 2457-2465, 2021 | 7 | 2021 |
| Biomaterials for cancer immunotherapy K Alhallak, J Sun, B Muz, AK Azab Biomaterials for Cancer Therapeutics, 499-526, 2020 | 7 | 2020 |
| Liposomal phytohemagglutinin: In vivo T‐cell activator as a novel pan‐cancer immunotherapy K Alhallak, J Sun, B Muz, A Jeske, J O’Neal, JK Ritchey, S Achilefu, ... Journal of Cellular and Molecular Medicine 26 (3), 940-944, 2022 | 6 | 2022 |
Abdel Kareem AzabAssociate Professor, Biomedical Engineering, University of Texas Southwestern Medical CenterVerified email at utsouthwestern.edu
